当前位置：
主页产品
详情

3,4,6-Tri-O-acetyl-alpha-D-galactopyranose 1,2-(methyl orthoacetate) | CAS:3254-16-8

3,4,6-Tri-O-acetyl-alpha-D-galactopyranose 1,2-(methyl orthoacetate)

名称：3,4,6-三-O-乙酰基-alpha-D-吡喃葡萄糖-1,2-(甲基原乙酸酯) | 3,4,6-Tri-O-acetyl-alpha-D-galactopyranose 1,2-(methyl orthoacetate)
CAS号：3254-16-8
别名：
分子式：C₁₅H₂₂O₁₀
分子量：362.33
EINESC号：

产品描述

物理化学性质

没有数据	没有数据

安全数据

没有数据	没有数据

SDS

来源	SDS样本
没有数据	没有数据

产品合成路线

名称	CAS号

文章

同行评议文献

Development and validation of chromatographic methods for simultaneous determination of ibuprofen and famotidine in presence of related substances in pharmaceutical formulationsElzanfaly ES, et al. Acta Chimica Slovenica, 62(1) (2014) FamotidinePharmacopeia, US United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020) RP-HPLC determination of famotidine and its potential impurities in pharmaceuticalsHelali N, et al. Chromatographia, 60(7-8) (2004) Photoaffinity labeling of the anionic sites in Caco-2 cells mediating saturable transport of hydrophilic cations ranitidine and famotidineBourdet DL, et al. Journal of medicinal chemistry, 47(11) (2004) Potentiometric determination of famotidine in pharmaceutical formulationsAyad MM, et al. Journal of Pharmaceutical and Biomedical Analysis, 29(1-2) (2002) Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticalsHelali N, et al. Talanta, 74(4) (2008) Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon columnHelali N and Monser L Journal of Separation Science, 31(2) (2008)

备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称	CAS号

产品描述

物理化学性质

安全数据

SDS

相关产品

相关资讯